Corporate Benefactors
Markel Corporation (NYSE-MKL) is a holding company based in Richmond, Virginia. Founded in 1930, Markel’s core businesses include underwriting specialty insurance and reinsurance. Markel operates 77 offices in 18 countries and is ranked number 311 on the most recent Fortune 500 listing. Markel Ventures, a subsidiary that makes strategic investments in companies outside of the insurance industry, owns a majority interest in 16 businesses. These companies are engaged in a mix of services and manufacturing — and their products range from commercial bakery equipment to concierge medicine to luxury handbags and leather goods. Each business is independently operated. Other Markel holdings that maintain independent brands are State National (fronting for property and casualty insurance programs) and Nephila (managing funds which hedge catastrophe and weather risks). In each of our businesses, we seek to deliver innovative products and responsive customer service so that we can be a market leader. Our time horizon is long- term, our underwriting approach is disciplined, and our focus is on continuously improving the quality of the customer experience. Our financial goals are to earn consistent underwriting and operating profits and to combine those profits with superior investment returns to build shareholder value. McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Our Stories. At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.
65
Made with FlippingBook - Online catalogs